Aroa Biosurgery Signs Exclusive U.S. Endoform Co-Promotion Deal
Aroa Biosurgery signed an exclusive co-promotion agreement with Mölnlycke Healthcare US for Endoform in U.S. post-acute settings, effective Oct. 16, 2026. Aroa retains ownership and manufacturing, and FY27 revenue and EBITDA guidance remain unchanged.